drugset / Trial / NCT06625840

A Study of MK-1167 in Healthy Elderly Participants (MK-1167-004)

NCT06625840

Phase 1 Completed 16 enrolled Merck Sharp & Dohme LLC
RandomizedSequentialTriple-blindBasic science

Summary

The goal of this study is to learn how safe MK-1167 is in healthy elderly adults and how well people tolerate it.

Timeline

Start
2023-09-18
Primary completion
2024-05-08
Completion
2024-05-08

Drugs

EvaluationDrugModalityDoseRoute
Subject MK-1167 Unknown Oral

Indications

No indication recorded.